company background image
506197 logo

Bliss GVS Pharma BSE:506197 Stock Report

Last Price

₹136.10

Market Cap

₹14.2b

7D

3.9%

1Y

71.1%

Updated

27 Feb, 2024

Data

Company Financials

Bliss GVS Pharma Limited

BSE:506197 Stock Report

Market Cap: ₹14.2b

506197 Stock Overview

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India.

506197 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Bliss GVS Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bliss GVS Pharma
Historical stock prices
Current Share Price₹136.10
52 Week High₹148.95
52 Week Low₹69.15
Beta0.98
1 Month Change22.28%
3 Month Change-3.82%
1 Year Change71.09%
3 Year Change-20.92%
5 Year Change-23.00%
Change since IPO53,384.97%

Recent News & Updates

Recent updates

Shareholder Returns

506197IN PharmaceuticalsIN Market
7D3.9%0.2%0.1%
1Y71.1%69.3%49.1%

Return vs Industry: 506197 exceeded the Indian Pharmaceuticals industry which returned 67.2% over the past year.

Return vs Market: 506197 exceeded the Indian Market which returned 49% over the past year.

Price Volatility

Is 506197's price volatile compared to industry and market?
506197 volatility
506197 Average Weekly Movement7.1%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market3.8%

Stable Share Price: 506197 has not had significant price volatility in the past 3 months.

Volatility Over Time: 506197's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984763Gagan Sharmahttps://www.blissgvs.com

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes.

Bliss GVS Pharma Limited Fundamentals Summary

How do Bliss GVS Pharma's earnings and revenue compare to its market cap?
506197 fundamental statistics
Market cap₹14.25b
Earnings (TTM)₹879.46m
Revenue (TTM)₹7.57b

16.2x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506197 income statement (TTM)
Revenue₹7.57b
Cost of Revenue₹4.08b
Gross Profit₹3.49b
Other Expenses₹2.61b
Earnings₹879.46m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)8.40
Gross Margin46.11%
Net Profit Margin11.62%
Debt/Equity Ratio10.3%

How did 506197 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

7%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.